The findings open the door to future research on how to control the regeneration of heart tissue in order to repair damage caused by disease or heart attack.
Findings from the three-year study could eventually lead to new personalized treatments for lung cancer, which is responsible for an estimated 29 percent of U.S. cancer deaths.
The funding from the California Institute of Regenerative Medicine will support Dr. John Chute's research aimed at creating new stem cell therapies for use in medical practice.
Two new gifts will fund research in stem cell science and digestive diseases and support faculty recruitment at two of UCLA's renowned research centers.